A phase I/II clinical trial of Devimistat in combination with Bendamustine in relapsed or refractory T-cell lymphoma patients
Latest Information Update: 21 Aug 2021
At a glance
- Drugs Devimistat (Primary) ; Bendamustine
- Indications T-cell lymphoma
- Focus Adverse reactions; Therapeutic Use
- 21 Aug 2021 New trial record